Bugging tumors to put drugs on target.
Juliano
Rudy
R
Department of Pharmacology and the Carolina Center of Cancer Nanotechnology Excellence, School of Medicine, University of North Carolina, Chapel Hill, USA.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001426:Bacterial Proteins / Q000378:metabolism; D003013:Clostridium / Q000235:genetics; D004317:Doxorubicin / Q000008:administration & dosage*; D016503:Drug Delivery Systems; D006801:Humans; D008049:Lipase / Q000235:genetics / Q000378:metabolism*; D008081:Liposomes; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D001426:Bacterial Proteins; D008081:Liposomes; D004317:Doxorubicin; D008049:Lipase